The Name on the Clinic: Who Owns Your Veterinarian, and What It Costs
Over the last decade a few large companies, some family-owned and most backed by private equity, have bought a large share of America's animal hospitals, usually keeping the local name. How big they are, why vets sell, what has happened to prices, what Britain's regulator found when it studied the same trend, and who regulates it here.
November 5, 2026
The short version
The cost of taking a pet to the vet has risen far faster than prices overall: 55% since 2019, against 31% for everything consumers buy, and about 259% since 2000, against 94%. Over the same years a handful of companies bought thousands of animal hospitals. The largest, Mars, the candy and pet-food company, owns VCA, Banfield and BluePearl; others are owned by private equity firms or by JAB, a Luxembourg-based investment firm that also owns pet insurers. Nobody counts the corporate share precisely; estimates run from about a quarter of general practices to three-quarters of specialty and emergency hospitals. We found no U.S. study measuring whether the new owners raised prices. Britain's competition regulator did study it, and found that large groups charged more than independents and that prices rose faster at practices after they were bought; it has ordered price lists, ownership disclosure and caps on some fees. In the U.S., the FTC has required one owner to give notice before buying even small specialty or emergency clinics near its own, and some states limit who can own a practice.
New articles and charts arrive in one short email on Monday mornings. Get the weekly digest
The analogy
A neighborhood bakery bought by a regional chain that keeps the baker, the sign and the recipes, and adds the chain's ordering system, its suppliers and its price list. Regular customers may notice only that the bread costs more, or that it doesn't; the hard question is which change caused which.
The bakery is the animal hospital. The chain is the corporate group that bought it.
Figures below are as of early November 2026.
How big the field is
The Census Bureau counted 34,296 veterinary establishments with employees in 2023, employing about 475,000 people; about four in five had fewer than 20 employees (Census Bureau, County Business Patterns). The BLS counted 91,100 veterinarian jobs in 2025, with median pay of $130,100 (BLS).
The corporate share is estimated, not counted. The estimates differ because they measure different things at different times:
- The consulting firm Brakke estimated in 2022 that corporate groups owned about 25% of primary-care practices, about 75% of specialty and emergency hospitals, and about half of the industry's revenue (Traub-Werner et al., Frontiers in Veterinary Science, 2025).
- In 2018 the American Veterinary Medical Association's news service reported an earlier Brakke estimate of about 10% of general companion-animal practices (AVMA).
- Then-FTC Chair Lina Khan said in 2024 that 25% to 30% of practices and nearly 75% of specialty clinics were corporate-owned (AVMA).
Most of these counts rely on what the groups report about themselves.
The big owners
Location counts are each group's own:
- Mars Veterinary Health, part of the family-owned Mars, Inc., has about 3,000 clinics worldwide (Mars Veterinary Health). In the U.S. that includes VCA, which Mars bought in 2017 for about $9.1 billion including debt (Mars), with more than 1,000 hospitals in the U.S., Canada and Japan; Banfield, with about 1,000 hospitals and clinics in the U.S., Mexico and Canada (Mars), hundreds of them in PetSmart stores (PetSmart); and BluePearl, with more than 100 specialty and emergency hospitals. Mars also owns Antech, a large diagnostic lab (Mars). Mars is not a private equity firm, but it grew in veterinary care through acquisitions.
- National Veterinary Associates (NVA), owned by JAB Holding, has about 1,000 general hospitals plus Ethos, its specialty and emergency arm, with more than 140 (NVA). NVA has said it is preparing for a public stock offering (NVA). JAB's 2025 annual report cited "persistent softness in U.S. veterinary traffic" (JAB).
- Mission Pet Health, formed by a merger of Southern Veterinary Partners and Mission Veterinary Partners completed in late 2024 and renamed in July 2025 (Mission Pet Health), reports more than 970 locations in 43 states (Mission Pet Health) and is backed by the private equity firms Shore Capital and Silver Lake (Today's Veterinary Business). Bloomberg reported in November 2024 that the firms were in talks over an $8.6 billion deal (Bloomberg Law).
- PetVet Care Centers, owned by KKR since 2017, reports more than 420 hospitals (PetVet).
- Thrive Pet Healthcare, owned by TSG Consumer Partners, reports more than 360; in 2025 a financing backed by its lenders and TSG added more than $350 million and extended its debt maturities (Thrive, via Animal Health News & Views).
- Retailers. Petco runs about 300 full-service hospitals and about 1,600 weekly Vetco clinics in its stores (Petco, annual report); Chewy had 18 clinics at the end of its 2025 fiscal year (Chewy, annual report).
Most of these groups keep a hospital's local name, sometimes with their own in front of it.
How the buying works
Private equity firms raise money from investors such as pension funds, university endowments, insurers and wealthy individuals, buy companies, try to make them more profitable, and sell them, often within several years (SEC, Investor.gov). The method used across Main Street businesses is called a roll-up. A fund buys one sizable group, the platform, then uses it to buy smaller practices one at a time, the add-ons, and runs them on shared systems for purchasing, staffing, billing and marketing. Part of the profit comes from pricing: a single practice sells for a lower multiple of its earnings than a large group does, so buying many small ones and combining them can create a company worth more than the pieces cost. Each of those small purchases is usually too small to require notice to federal antitrust regulators (see below).
Why vets sell
Price. A broker that sells practices says clinics now sell for 8 to 15 times their yearly earnings before interest, taxes, depreciation and amortization, up from 4 to 6 times before 2017, and that the Southern–Mission merger was valued at 17 to 18 times (Ackerman Group).
Who else could buy. In a survey by Veterinary Management Groups of former members who sold to corporations, 47% said they wanted to take advantage of high sale prices; 71% said they would have preferred to sell to an associate veterinarian, and 59% said the associate couldn't afford to buy, according to a 2025 paper whose authors include the group's staff (Frontiers in Veterinary Science). New veterinarians graduated in 2026 with an average of $185,424 in student debt (AVMA).
Demand. Americans spent $158 billion on their pets in 2025, $41 billion of it on vet care and products, according to the industry's trade group (American Pet Products Association; industry statistics). Many clinics also sell wellness plans, monthly fees that cover routine care, which give the owners steady, recurring revenue.
What vet care costs
The BLS price index for veterinarian services rose 55.0% from September 2019 to September 2026, while consumer prices overall rose 31.2%. Since September 2000 it has risen about 259%, against 94% overall. In the 12 months to September 2026 it rose 4.6%, against 3.7% (BLS, veterinarian services; BLS, all items).
Price change: vet care and all consumer prices
Vet care was rising faster than prices overall before most of the buying began: from September 2000 to September 2015 the index rose 105%, against 37% for all items (same sources). Mars attributes recent increases to diagnostics and treatments "that did not exist a generation ago," staff shortages and rising supply costs (PBS NewsHour). We found no U.S. study measuring prices at corporate-owned clinics against independent ones. The closest, a 2025 study by the economist Sandro Steinbach using data from 2000 to 2021, found that after a corporate practice entered a census tract, by purchase or new opening, independent practices there were 1.9% more likely to exit and had 6.9% lower revenue (Journal of the Agricultural and Applied Economics Association). That is evidence about competition, not about prices.
What Britain found
Britain's Competition and Markets Authority investigated its vet market from September 2023 to March 2026 (CMA). Its final report found (CMA):
- Large groups owned about 60% of practices in the UK, up from about 10% in 2013.
- Vet prices rose about 63% from 2016 to 2023, against 32% for consumer prices overall.
- Five of the six large groups charged on average 18.3% more than independents; the evidence for the sixth was inconclusive.
- At at least three of those five, prices were about 9% higher four years after buying a practice than its earlier trend would have predicted.
- Pet owners often didn't know who owned their vet, and price information was hard to find.
The authority estimated harm to consumers of around £1 billion over five years at general practices, and said it could be higher. Its order, made in September 2026, requires published price lists, disclosure of who owns a practice, written estimates for treatment of £500 or more, and caps on prescription fees at the larger groups, phasing in from December 2026 through September 2027 (CMA; CMA).
Whether this carries over is uncertain. Corporate ownership is more extensive in Britain, and its market, regulation and pet insurance differ. We found no comparable U.S. study.
Workers
Whether there is a shortage of veterinarians is disputed. A 2023 forecast commissioned by Mars projected a shortage of 14,000 to 24,000 companion-animal vets by 2030 (Mars Veterinary Health); a study commissioned by the AVMA and published in 2024 found that existing veterinary schools would meet demand through 2035 (AVMA). A survey published in 2024 found 18% of veterinarians reporting high or very high burnout, against 16% in a survey of U.S. adults (Journal of the American Veterinary Medical Association). We found no rigorous public comparison of pay at corporate and independent practices.
Senators Elizabeth Warren and Richard Blumenthal wrote that corporate groups make frequent use of noncompete agreements, which keep a veterinarian from practicing nearby after leaving (letter to Mars). The FTC's 2024 rule banning most noncompetes was set aside by a federal judge in Texas in August 2024, and the FTC abandoned it in 2025 (Today's Veterinary Business). California law has long voided most noncompetes (Cal. Bus. & Prof. Code § 16600).
Who regulates it
The FTC. In 2022 the FTC challenged two purchases by JAB, of SAGE Veterinary Centers and of Ethos, both chains of specialty and emergency hospitals. It required JAB to sell clinics in several markets, including the San Francisco Bay Area. For ten years JAB must get the FTC's approval before buying specialty or emergency clinics within 25 miles of its own in California and other named states, and must give 30 days' notice nationwide before buying any specialty or emergency clinic within 25 miles of one of its own, even when the deal is too small to require a standard merger filing (FTC; FTC). Holly Vedova, then director of the FTC's Bureau of Competition, said those provisions would give the agency "full visibility into future consolidation" (same source). The FTC said JAB's clinics were the only provider in some markets and one of two in others (FTC). We found no FTC merger action on vet clinics since; in 2025 it ordered Gateway, a pet-cremation company that serves vet practices, to stop enforcing noncompetes (Today's Veterinary Business). Companies must notify the FTC and the Justice Department before a merger only if the deal is worth more than a threshold, $133.9 million in 2026; the purchase of a single clinic typically falls far below it, so most are never reported (FTC).
Congress. In 2024 Senators Warren and Blumenthal asked JAB about prices, staffing, insurance and dividends, and Mars about noncompetes and diagnostic lab pricing (letter to JAB; letter to Mars). We found no federal legislation that followed.
The states. Some states limit ownership of vet practices by non-veterinarians, among them New York and Iowa (New York Education Law § 6706; Iowa Code § 169.4A); an industry advocate counts about 18 (Today's Veterinary Business). Investors there sometimes use a company owned by a veterinarian paired with a management company (Arnall Golden Gregory). California law doesn't prohibit corporate ownership, but each hospital must be registered with a licensed veterinarian as its manager (California Veterinary Medical Board).
Pet insurance
Americans paid about $5.7 billion in pet insurance premiums in 2025, up about 20% in a year, though only about 4% of pets were insured (North American Pet Health Insurance Association). JAB, which owns NVA, also owns pet insurers covering more than 6 million pets (JAB), grouped since June 2026 under the name Doubtless (Doubtless); among them is Spot (JAB). That puts some of the clinics and some of the insurers that pay for care under one owner. Senators Warren and Blumenthal wrote that this may let JAB favor its own insurance brands (letter to JAB); we found no evidence that it does.
Where the analogy breaks
Bread is bought every week, and a customer who thinks it costs too much can try another bakery. A pet emergency comes rarely and without warning, an owner seldom knows what the treatment should cost, and specialty and emergency care, where corporate ownership is highest, may have only one or two providers in a market, as the FTC found in its JAB cases.
What people argue about
Prices. Mars says rising prices reflect new diagnostics and treatments, staff shortages and supply costs, and that its vets have clinical autonomy (PBS NewsHour). Greg Hartmann, then NVA's chief executive, said NVA doesn't "view price increases as a way of enabling or justifying the investment in a hospital" (Freakonomics). Senators Warren and Blumenthal, citing Fortune, described a cat's rabies shot at a New York City clinic that cost $27 in 2018 and $50 in 2024, after the clinic was sold to a private equity–backed company in 2022 (letter to JAB). Britain's regulator found higher prices at large groups; we found no U.S. study that has tested it.
Independents. Mark Cushing of the Animal Policy Group, which advises the industry, argues that bills restricting corporate ownership cite no documented evidence of harm (Today's Veterinary Business). An independent practice owner told PBS that corporate groups' volume buying lets them pay far less for supplies (PBS NewsHour), and Steinbach's study found independents losing revenue when a corporate practice enters nearby. Matt Salois, an economist and president of Veterinary Management Groups, told PBS that private equity's entry "in and itself is not good or bad," that it is part of the price story, and that trust becomes harder to keep as a practice grows (same source).
Owners and new vets. For a retiring owner, a corporate buyer may be the only one able to pay what the practice is worth, and a corporate partner can supply the capital for a new one: a couple who opened a new practice in 2023 did so with a corporate co-owner (Today's Veterinary Business). In the Veterinary Management Groups survey, most former owners who sold to corporations said they would rather have sold to an associate (Frontiers in Veterinary Science).
What to require. Britain chose disclosure, of prices and of owners, along with some caps. In the U.S. the debate is at an earlier stage: whether to study the market at all, and whether notice requirements like the FTC's for JAB should apply more widely.
See also
- The name on the dentist's door: the same buying pattern in dentistry, part 2 of this series.
- The name on the truck: the same pattern in heating, plumbing and electrical work.
- What is inflation?: how the price indexes on this page are built.
Sources
- Size and share: Census Bureau, County Business Patterns 2023; BLS, Occupational Outlook Handbook; Traub-Werner et al., Frontiers in Veterinary Science, 2025; AVMA on corporatization (2018) and Khan's remarks (2024).
- The groups: Mars Veterinary Health and its companies; Mars, on VCA (January 9, 2017); PetSmart; Mars petcare brands; NVA and its IPO plans (May 2025); JAB, 2025 annual report; Mission Pet Health, renaming (July 21, 2025) and home page; Today's Veterinary Business, capital review; Bloomberg Law (November 2024); PetVet; Thrive, via Animal Health News & Views; Petco, annual report; Chewy, annual report.
- Why vets sell: Ackerman Group (2025); AVMA, on graduate debt (2026); American Pet Products Association, 2025 spending and industry statistics.
- Prices: BLS consumer price index, veterinarian services and all items; Steinbach, 2025; PBS NewsHour (July 1, 2026).
- Britain: Competition and Markets Authority, final report summary (March 24, 2026), order (September 22, 2026) and guidance for large businesses.
- How private equity works: SEC, Investor.gov.
- Workers: Mars Veterinary Health, workforce forecast (August 2023); AVMA, on its workforce study (2024); JAVMA, wellbeing study (2024); Today's Veterinary Business, on noncompetes; Cal. Bus. & Prof. Code § 16600.
- Regulation: FTC on JAB and SAGE (June 2022) and JAB and Ethos (October 2022); FTC, merger-filing thresholds; Senators Warren and Blumenthal to JAB (August 2024) and Mars (November 2024); New York Education Law § 6706; Iowa Code § 169.4A; Arnall Golden Gregory; California Veterinary Medical Board (2018).
- Pet insurance: NAPHIA, 2026 report; Doubtless (June 2026); JAB, on Spot.
- The arguments: Freakonomics (January 2023); Today's Veterinary Business, Cushing's column (August 2026) and on a new practice.